Star shortstop Carlos Correa, the owner of a World Series ring and 18 career postseason home runs, finally has a long-term home.
The Minnesota Twins just signed him to a six-year, $200 million contract this week, with the chance to earn $70 additional million over four years.
Deals with the San Francisco Giants and the New York Mets fell through due to concerns with his right leg/ankle.
The Twins, familiar with his medical records and having hosted him for a season in 2022, decided to take the risk and take advantage of the slight discount to lure him back.
Speaking with the media on Wednesday, the star infielder spoke about his medical journey during the offseason.
“’One thing I learned throughout the whole process is that doctors have differences of opinions. I had a lot of doctors tell me that I was fine, some doctors that said it wasn’t so fine.’ – Carlos Correa,” SNY tweeted, with his quotes.
“One thing I learned throughout the whole process is that doctors have differences of opinions. I had a lot of doctors tell me that I was fine, some doctors that said it wasn't so fine."
– Carlos Correa pic.twitter.com/ubgYRzgvOY
— SNY (@SNYtv) January 11, 2023
That is a real thing, and it can happen.
It happens to the average person in life: not every doctor has the exact same opinion of a disease, illness, or condition.
In Correa’s case, evidently the Giants’ and Mets’ medical professionals were too worried that his leg would eventually be an issue that would force him to miss time or affect his performance.
The Twins, desperate for top-end talent, are more willing to accept the potential outcomes.
Additionally, the Twins have enviable organizational shortstop depth to cope in case of an extended absence.
At the end of the day, Correa ended up returning to the team with which he enjoyed success in 2022.
The Twins are a dangerous dark horse in 2023.